Table 1. Characteristics of included studies that contributed to associations between rs144848 and cancer risk.
Study [ref] per SNP | Year | Race/ethnicity | Sourcea | Cases | Controls | Allele frequencies | NOS assessment | Cancer type | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | NN | NH | HH | Total | NN | NH | HH | Casesb | Controlsb | ||||||
Healey et al. [12] | 2000 | Caucasian | PB | 234 | 116 | 99 | 19 | 266 | 138 | 115 | 13 | 0.71 | 0.73 | 7 | Breast |
Healey et al. [12] | 2000 | Caucasian | PB | 1667 | 858 | 664 | 145 | 1201 | 631 | 493 | 77 | 0.71 | 0.73 | 7 | Breast |
Healey et al. [12] | 2000 | Caucasian | PB | 450 | 236 | 180 | 34 | 228 | 124 | 94 | 10 | 0.72 | 0.75 | 7 | Breast |
Healey et al. [12] | 2000 | Caucasian | PB | 659 | 325 | 285 | 49 | 866 | 433 | 373 | 60 | 0.71 | 0.72 | 7 | Breast |
Healey et al. [12] | 2000 | Caucasian | PB | 449 | 270 | 154 | 25 | 453 | 277 | 152 | 24 | 0.77 | 0.78 | 7 | Breast |
Spurdle et al. [45] | 2002 | Caucasian | PB | 1397 | 720 | 548 | 129 | 775 | 417 | 308 | 50 | 0.71 | 0.74 | 7 | Breast |
Ishitobi et al. [22] | 2003 | Asian | HB | 149 | 97 | 47 | 5 | 144 | 85 | 56 | 3 | 0.81 | 0.78 | 7 | Breast |
Menzel et al. [24] | 2004 | Caucasian | PB | 211 | 104 | 91 | 16 | 912 | 482 | 361 | 69 | 0.71 | 0.73 | 7 | Breast |
Menzel et al. [24] | 2004 | Caucasian | PB | 94 | 53 | 35 | 6 | 152 | 84 | 57 | 11 | 0.75 | 0.74 | 7 | Breast |
Cox et al. [44] | 2005 | Caucasian | Nested | 1285 | 695 | 501 | 89 | 1660 | 884 | 647 | 129 | 0.74 | 0.73 | 7 | Breast |
Millikan et al. [25] | 2005 | African | PB | 762 | 564 | 183 | 15 | 675 | 510 | 153 | 12 | 0.86 | 0.87 | 7 | Breast |
Millikan et al. [25] | 2005 | Caucasian | PB | 1265 | 662 | 521 | 82 | 1135 | 579 | 467 | 89 | 0.73 | 0.72 | 7 | Breast |
Garcia-Closas et al. [21] | 2006 | Caucasian | PB | 3161 | 1617 | 1278 | 266 | 2701 | 1412 | 1057 | 232 | 0.71 | 0.72 | 7 | Breast |
Garcia-Closas et al. [21] | 2006 | Caucasian | PB | 1968 | 1007 | 826 | 135 | 2276 | 1239 | 897 | 140 | 0.72 | 0.74 | 7 | Breast |
Johnson et al. [47] | 2007 | Caucasian | NA | 473 | 233 | 201 | 39 | 2461 | 1278 | 993 | 190 | 0.71 | 0.72 | 6 | Breast |
Palli et al. [48] | 2007 | Caucasian | PB | 91 | 48 | 31 | 12 | 261 | 127 | 107 | 27 | 0.70 | 0.69 | 6 | Breast |
Baynes et al. [46] | 2007 | Caucasian | PB | 4537 | 2306 | 1892 | 339 | 4339 | 2182 | 1824 | 333 | 0.72 | 0.71 | 7 | Breast |
Seymour et al. [49] | 2008 | Caucasian | HB | 252 | 127 | 111 | 14 | 100 | 50 | 44 | 6 | 0.72 | 0.72 | 6 | Breast |
Dombernowsky et al. [19] | 2009 | Caucasian | PB | 1200 | 604 | 503 | 93 | 4119 | 2129 | 1677 | 313 | 0.71 | 0.72 | 6 | Breast |
Juwle et al. [23] | 2012 | Asian | NA | 100 | 68 | 28 | 4 | 50 | 39 | 8 | 3 | 0.82 | 0.86 | 6 | Breast |
Hasan et al. [11] | 2013 | African | HB | 100 | 38 | 33 | 29 | 100 | 33 | 32 | 35 | 0.55 | 0.49 | 6 | Breast |
Jumaah et al. [50] | 2014 | African | NA | 36 | 26 | 10 | 0 | 10 | 10 | 0 | 0 | 0.86 | 1.00 | 6 | Breast |
Auranen et al. [26] | 2003 | Caucasian | PB | 680 | 355 | 272 | 53 | 1546 | 819 | 629 | 98 | 0.72 | 0.73 | 7 | Ovarian |
Auranen et al. [26] | 2003 | Caucasian | PB | 441 | 222 | 176 | 43 | 1097 | 578 | 445 | 74 | 0.70 | 0.73 | 7 | Ovarian |
Wenham et al. [28] | 2003 | Caucasian | PB | 312 | 169 | 128 | 15 | 398 | 227 | 146 | 25 | 0.75 | 0.75 | 7 | Ovarian |
Beesley et al. [32] | 2007 | Caucasian | PB | 492 | 249 | 203 | 40 | 948 | 502 | 383 | 63 | 0.71 | 0.73 | 8 | Ovarian |
Beesley et al. [32] | 2007 | Caucasian | PB | 930 | 460 | 401 | 69 | 825 | 461 | 296 | 68 | 0.71 | 0.74 | 8 | Ovarian |
Ramus et al. [36] | 2008 | Mixed | Nested | 4174 | 2196 | 1655 | 323 | 7402 | 3859 | 2979 | 564 | 0.72 | 0.72 | 7 | Ovarian |
Quaye et al. [37] | 2009 | Caucasian | PB | 1459 | 779 | 569 | 111 | 2294 | 1200 | 925 | 169 | 0.73 | 0.72 | 7 | Ovarian |
Shen et al. [30] | 2006 | Mixed | PB | 476 | 250 | 191 | 35 | 555 | 301 | 220 | 34 | 0.73 | 0.74 | 7 | NHLc |
Scott et al. [33] | 2007 | Caucasian | PB | 757 | 387 | 307 | 63 | 676 | 375 | 253 | 48 | 0.71 | 0.74 | 7 | NHL |
Shen et al. [34] | 2007 | Caucasian | PB | 556 | 271 | 236 | 49 | 498 | 246 | 203 | 49 | 0.70 | 0.70 | 7 | NHL |
Hill et al. [16] | 2006 | Mixed | PB | 1116 | 577 | 441 | 98 | 926 | 505 | 361 | 60 | 0.71 | 0.74 | 7 | NHL |
Salagovic et al. [39] | 2012 | Caucasian | HB | 107 | 62 | 34 | 11 | 127 | 82 | 40 | 5 | 0.74 | 0.80 | 7 | NHL |
Hu et al. [27] | 2003 | Asian | PB | 120 | 69 | 39 | 12 | 231 | 126 | 95 | 10 | 0.74 | 0.75 | 6 | Esophageal |
Wu et al. [31] | 2006 | Caucasian | PB | 604 | 306 | 246 | 52 | 595 | 332 | 223 | 40 | 0.71 | 0.75 | 8 | Bladder |
Debniak et al. [35] | 2008 | Caucasian | Nested | 627 | 288 | 280 | 59 | 3819 | 1994 | 1580 | 245 | 0.68 | 0.73 | 6 | Melanoma |
Agalliu et al. [15] | 2010 | Caucasian | PB | 1269 | 655 | 498 | 116 | 1243 | 654 | 500 | 89 | 0.71 | 0.73 | 8 | Prostate |
Agalliu et al. [15] | 2010 | African | PB | 142 | 104 | 36 | 2 | 79 | 59 | 18 | 2 | 0.86 | 0.86 | 8 | Prostate |
Kotnis et al. [38] | 2012 | Asian | HB | 109 | 35 | 56 | 18 | 186 | 81 | 70 | 35 | 0.58 | 0.62 | 7 | Multiple |
a Source in control, PB population-based study, HB hospital-based study
b Major allele frequency
c non-Hodgkin lymphoma